Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo

[1]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[2]  F. Cao,et al.  Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene. , 2006, Biomedical and environmental sciences : BES.

[3]  S. Madersbacher,et al.  Phytotherapie bei BPS , 2005, Der Urologe, Ausgabe A.

[4]  R. Macdonald,et al.  Phytoestrogens in Common Herbs Regulate Prostate Cancer Cell Growth in Vitro , 2004, Nutrition and cancer.

[5]  M. Gleave,et al.  Protein kinase C‐α in prostate cancer , 2004 .

[6]  M. Rubin,et al.  Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee , 2004, Cancer Research.

[7]  S. Ho.  Estrogens and anti‐estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates , 2004, Journal of cellular biochemistry.

[8]  K. M. Strong.  African Plum and Benign Prostatic Hypertrophy , 2004, Journal of herbal pharmacotherapy.

[9]  Inmaculada Hernández,et al.  Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. , 2003, Molecular cancer research : MCR.

[10]  S. Downing,et al.  Alterations of p53 are common in early stage prostate cancer. , 2003, The Canadian journal of urology.

[11]  Tsuey-Ming Chen,et al.  Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model , 2003, The Prostate.

[12]  A. Cassidy.  Potential risks and benefits of phytoestrogen-rich diets. , 2003, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[13]  M. Steiner,et al.  Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk , 2003, World Journal of Urology.

[14]  U. Jonas,et al.  [Phytotherapy of benign prostatic hyperplasia. Current evidence-based evaluation]. , 2002, Der Urologe. Ausg. A.

[15]  G. Gerber.  Phytotherapy for benign prostatic hyperplasia , 2002, Current urology reports.

[16]  P. K. Gathumbi,et al.  Toxicity of chloroform extract of Prunus africana stem bark in rats: gross and histological lesions , 2002, Phytotherapy research : PTR.

[17]  K. Dreikorn.  The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia , 2002, World Journal of Urology.

[18]  Weida Tong,et al.  Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. , 2002, The Journal of nutrition.

[19]  U. Kim,et al.  In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[20]  E. Rimm,et al.  A prospective study on intake of animal products and risk of prostate cancer , 2001, Cancer Causes & Control.

[21]  T. Wilt,et al.  Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. , 2000, The American journal of medicine.

[22]  T. Wilt,et al.  Phytotherapy for benign prostatic hyperplasia , 2000, Public Health Nutrition.

[23]  A. Awad,et al.  Phytosterols as anticancer dietary components: evidence and mechanism of action. , 2000, The Journal of nutrition.

[24]  R. Levin,et al.  A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens , 2000, Urological Research.

[25]  T. Senge,et al.  Effect of Beta–Sitosterol on Transforming Growth Factor–Beta–1 Expression and Translocation Protein Kinase C Alpha in Human Prostate Stromal Cells in vitro , 2000, European Urology.

[26]  T. Senge,et al.  Treatment of symptomatic benign prostatic hyperplasia with β‐sitosterol: an 18‐month follow‐up , 2000, BJU international.

[27]  J. Trachtenberg,et al.  Nutritional aspects of prostate cancer: a review. , 2000, The Canadian journal of urology.

[28]  A. Awad,et al.  Effect of Β-Sitosterol, a Plant Sterol, on Growth, Protein Phosphatase 2A, and Phospholipase D in LNCaP Cells , 2000, Nutrition and cancer.

[29]  T. Wilt,et al.  Beta-sitosterols for benign prostatic hyperplasia. , 1999, The Cochrane database of systematic reviews.

[30]  K. Griffiths,et al.  Diet and Its Preventive Role in Prostatic Disease , 1999, European Urology.

[31]  T. Wilt,et al.  Pygeum africanum for benign prostatic hyperplasia. , 1998, The Cochrane database of systematic reviews.

[32]  B. Foster,et al.  Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. , 1997, Cancer research.

[33]  F. Stephens,et al.  Phytoestrogens and prostate cancer: possible preventive role , 1997, The Medical journal of Australia.

[34]  J. Riffaud,et al.  Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts. , 1997, The Journal of urology.

[35]  C. Roberts,et al.  Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor. , 1996, Endocrinology.

[36]  R. Miksicek.  Estrogenic Flavonoids: Structural Requirements for Biological Activity , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[37]  M. Paubert-Braquet,et al.  Effect of Pygeum africanum extract on A23187-stimulated production of lipoxygenase metabolites from human polymorphonuclear cells. , 1994, Journal of lipid mediators and cell signalling.

[38]  R. Matusik,et al.  The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. , 1994, Molecular endocrinology.

[39]  A. Witeska,et al.  Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic hyperplasia: double-blind comparison of two doses. , 1993, Clinical therapeutics.

[40]  R. Bar,et al.  Cyclodextrins as carriers of cholesterol and fatty acids in cultivation of mycoplasmas , 1993, Applied and environmental microbiology.

[41]  A. Granata,et al.  [Urological and sexual evaluation of treatment of benign prostatic disease using Pygeum africanum at high doses]. , 1991, Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences.

[42]  A. Aubert,et al.  [Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study]. , 1990, Wiener klinische Wochenschrift.

[43]  H. Willard,et al.  Cloning of human androgen receptor complementary DNA and localization to the X chromosome. , 1988, Science.

[44]  B. Dufour,et al.  [Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma]. , 1984, Annales d'urologie.

[45]  K. AhmadSamhan.  Treatment of prostatic disorders with a combination of Prunus africana and benzidamine , 1980 .

[46]  R. Macdonald,et al.  Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer. , 2004, The Journal of nutrition.

[47]  J. Morote Robles,et al.  [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia]. , 2003, Archivos espanoles de urologia.

[48]  J. Breza,et al.  Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe. , 1998, Current medical research and opinion.

[49]  A. Awad,et al.  beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. , 1998, Nutrition and cancer.

[50]  G. Mathé,et al.  The so-called phyto-estrogenic action of Pygeum africanum extract. , 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[51]  G. Mathé,et al.  A Pygeum africanum extract with so-called phyto-estrogenic action markedly reduces the volume of true and large prostatic hypertrophy. , 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.